Pfizer Limited
The Capital, 1802/1901,
Plot No. C - 70, G Block, Bandra Kurla Complex,
Bandra (East), Mumbai 400 051.
Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
October 28, 2024 | |
The Corporate Relationship Dept. | The Manager, Listing Dept. |
BSE Limited | The National Stock Exchange of India Ltd. |
1st Floor, P.J.Towers | Exchange Plaza, 5th Floor, Plot No. C/1, |
Dalal Street, Fort | G Block Bandra-Kurla Complex, Bandra (E) |
Mumbai - 400 001 | Mumbai - 400 051 |
Scrip Code: 500680 | Scrip Symbol: PFIZER |
Dear Sirs, |
Sub: Outcome of the Board Meeting-Unaudited Financial Results for the quarter and half year ended September 30, 2024.
Ref: Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations").
Pursuant to the Regulation 33 of the Listing Regulations, we submit herewith the Unaudited Financial Results for the quarter and half year ended September 30, 2024, which were approved by the Board of Directors of the Company at their Meeting held today, that commenced at 3.00 p.m. and concluded at 5.45 p.m.
Also please find enclosed the Limited Review Report issued by the Statutory Auditors namely, B. S. R. & Co., LLP, in respect of the said Unaudited Financial Results.
We request you to kindly take the same on record.
Thanking you,
Your truly,
For Pfizer Limited
PRAJEET NAIR
Prajeet Nair
Digitally signed by
PRAJEET NAIR Date: 2024.10.28 17:58:08 +05'30'
Director - Corporate Services & Company Secretary
Cc.: National Securities Depository Limited (NSDL)
Central Depository Services (India) Limited (CDSL)
KFin Technologies Limited
CIN: L24231MH1950PLC008311
Email ID: contactus.india@pfizer.com
Website: www.pfizerltd.co.in